MPO, a pro-inflammatory enzyme secreted in large quantities by activated myeloid cells following stroke, plays a critical role in the pathogenesis of both hemorrhagic and ischemic strokes, contributing to blood-brain barrier (BBB) disruption and subsequent brain injury (Wang et al., 2022). The gene discussed is MPO; the disease is ischemic stroke.